Subclavian Introducer Set
Infusaid
FDA Clearance Information
The subclavian introducer set was cleared by the FDA through the 510(k) pathway on July 31, 1990. It is manufactured by Infusaid and classified as a Class 2 device.
What It Is
FDA-Cleared Indications
- Facilitation of catheter placement through the subclavian vein for central venous access.
- Access for placement of pacemaker or defibrillator leads.
- Access for catheter placement during hemodynamic studies.
- Access for ventriculovenous shunt procedures.
Clinical Applications
- Obtaining subclavian venous access for central venous catheter placement.
- Facilitating placement of pacemaker leads.
- Facilitating placement of defibrillator leads.
- Providing access for selected hemodynamic studies.
- Providing access for ventriculovenous shunt procedures.
Evidence Summary
Reported Outcomes
Safety Profile
Evidence Limitations
Practical Considerations
- The set is intended for venous access through the subclavian region; the exact introducer, dilator, sheath and catheter dimensions should be matched to the planned procedure.
- Use requires sterile technique and imaging or physiologic guidance appropriate to the procedure. Operators should confirm venous entry and catheter position before use.
- Potential complications of subclavian venous access include bleeding, hematoma, infection, arterial puncture, pneumothorax, hemothorax, thrombosis and air embolism.
- MRI safety depends on the specific components and whether any device remains in the patient. Do not assume MRI compatibility from the introducer-set name; check the current product labeling.
- Contraindications and precautions include infection at the access site, uncorrected significant bleeding risk, thrombosis or occlusion of the intended vein, and inability to safely identify or access the vessel.
Frequently Asked Questions
What are the clinical indications for subclavian introducer set?
The subclavian introducer set is indicated for procedures requiring central venous access, such as the placement of pacemaker leads and long-term central venous catheters.
What outcomes have been reported in clinical studies?
Clinical studies have reported high success rates in catheter and lead placement, with shorter procedure times and fewer complications using the medial approach.
What complications have been reported?
Safety data from studies indicate a low incidence of major complications, with some studies reporting no major complications during the use of the device.